Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Lung Cancer Screening clinical trials
4 of 8 indexed Lung Cancer Screening trials are currently recruiting.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · 4 currently recruiting · #2,176 of 28,707 conditions by registered trial count
Lung Cancer Screening: 8 US clinical trials tracked, 4 recruiting.
Lung Cancer Screening is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. The most active sponsor is Kaiser Permanente, running 1 of these trials.
Enrollment posture brief
Registry condition lung-cancer-screening
OPEN 4 | RECR 50% | LATE 0 | EARLY 0 | RANK #2176 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Lung Cancer Screening lists 4 open slots (50% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Lung Cancer Screening on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Lung Cancer Screening is recruiting above its size-band peers.
4 of 8 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Lung Cancer Screening trials is spread across many organizations.
Kaiser Permanente accounts for 1 of 8 trials (12.5%). 8 distinct sponsors appear on at least one study for this condition label.
-
Typical Lung Cancer Screening enrolment sits around 340 participants.
Median target enrolment is 340 among the 8 trials that report a genuine target (sentinel values excluded). 2 of those (25%) plan for fewer than 100 participants.
-
Lung Cancer Screening splits between interventional and observational designs.
5 interventional and 3 observational studies make up this index (62.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
8 total, page 1 of 1
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer
University of Maryland, Baltimore
NCT07008664
A Study of Lung Cancer Screening in People With Unexplained Weight Loss
Memorial Sloan Kettering Cancer Center
NCT06717334
CPRIT: Patient Adherence to Lung Cancer Screening
M.D. Anderson Cancer Center
NCT06872723
Advancing Lung Cancer Screening One Text at a Time
University of Rochester
NCT07227480
Multilevel Interventions to Increase Adherence to Lung Cancer Screening
Kaiser Permanente
NCT05747443
Digitally Enhanced Smoking Cessation for High Risk Smokers
Dana-Farber Cancer Institute
NCT04691297
Incorporating Veterans' Preferences Into Lung Cancer Screening Decisions
VA Office of Research and Development
NCT02899754
The SHARED, Project, Lung Cancer Screening for African American Men (AAM)
University of Illinois at Chicago
NCT05920850
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Lung Cancer Screening records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Lung Cancer Screening trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Lung Cancer Screening page
8 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Lung Cancer Screening trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Kaiser Permanente sponsors the most Lung Cancer Screening trials on record, review their full trial history before evaluating a specific study. See Kaiser Permanente's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Lung Cancer Screening condition card totals 8 registered trials; most-linked intervention Lung Cancer Screening Decision Tool; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.